Faculty of Social Sciences
Zoek in de site...
Delen

Secondary publications

Secondary publications

These papers used the summary statistics from the ICC papers

  • Reed, Z. E., Wootton, R. E., & Munafò, M. R. (2022). Using Mendelian randomization to explore the gateway hypothesis: possible causal effects of smoking initiation and alcohol consumption on substance use outcomes. Addiction, 117(3), 741-750. https://doi.org/10.1111/add.15673
  • Wormington, B., Thorp, J. G., Scott, J. G., & Derks, E. M. (2022). Influences on the genetic relationship between cannabis use and schizophrenia: the role of the externalizing spectrum. Schizophrenia Bulletin, 48(6), 1318-1326. https://doi.org/10.1093/schbul/sbac095
  • Paul, S. E., Hatoum, A. S., Barch, D. M., Thompson, W. K., Agrawal, A., Bogdan, R., & Johnson, E. C. (2022). Associations between cognition and polygenic liability to substance involvement in middle childhood: Results from the ABCD Study. Drug and Alcohol Dependence, 232, 109277. https://doi.org/10.1016/j.drugalcdep.2022.109277
  • Alayash, Z., Nolde, M., Meisinger, C., Baurecht, H., & Baumeister, S. E. (2021). Cannabis use and obesity-traits: a Mendelian randomization study. Drug and Alcohol Dependence, 226, 108863. https://doi.org/10.1016/j.drugalcdep.2021.108863
  • Jefsen, O. H., Speed, M., Speed, D., & Østergaard, S. D. (2021). Bipolar disorder and cannabis use: A bidirectional two‐sample Mendelian randomization study. Addiction Biology, 26, e13030. https://doi.org/10.1111/adb.13030
  • Alayash, Z., Nolde, M., Meisinger, C., Baurecht, H., & Baumeister, S. E. (2021). Cannabis use and obesity-traits: A Mendelian randomization study. Drug and Alcohol Dependence, 226, 108863. https://doi.org/10.1016/j.drugalcdep.2021.108863
  • Baumeister, S. E., Nolde, M., Alayash, Z., Leitzmann, M., Baurecht, H., & Meisinger, C. (2021). Cannabis use does not impact on type 2 diabetes: a two‐sample Mendelian randomization study. Addiction Biology, 26, e13020. https://doi.org/10.1111/adb.13020
  • Rosoff, D. B., Yoo, J., & Lohoff, F. W. (2021). A genetically-informed study disentangling the relationships between tobacco smoking, cannabis use, alcohol consumption, substance use disorders and respiratory infections, including COVID-19. Preprint retrieved from medRxiv:https://www.medrxiv.org/content/10.1101/2021.02.11.21251581v1.full.pdf
  • Vilar‐Ribó, L., Sánchez‐Mora, C., Rovira, P., Richarte, V., Corrales, M., Fadeuilhe, C., ... & Soler Artigas, M. (2021). Genetic overlap and causality between substance use disorder and attention‐deficit and hyperactivity disorder. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 186, 140-150. https://doi.org/10.1002/ajmg.b.32827
  • Johnson, E. C., Tillman, R., Aliev, F., Meyers, J. L., Salvatore, J. E., Anokhin, A. P., ... & Agrawal, A. (2019). Exploring the relationship between polygenic risk for cannabis use, peer cannabis use and the longitudinal course of cannabis involvement. Addiction, 114, 687-697. https://doi.org/10.1111/add.14512
  • Wang, X., Liu, Z., & Liu, W. (2020). Does Cannabis Intake Protect Against Non-alcoholic Fatty Liver Disease? A Two-Sample Mendelian Randomization Study. Frontiers in genetics, 11, 949. doi: https://doi.org/10.3389/fgene.2020.00949
  • Chang, L. H., Ong, J. S., An, J., Verweij, K. J., Vink, J. M., Pasman, J., ... & Derks, E. M. (2020). Investigating the genetic and causal relationship between initiation or use of alcohol, caffeine, cannabis and nicotine. Drug and Alcohol Dependence, 107966. doi: https://doi.org/10.1016/j.drugalcdep.2020.107966
  • Meyers, J. L., Salvatore, J. E., Aliev, F., Johnson, E. C., McCutcheon, V. V., Su, J., ... & Wang, J. C. (2019). Psychosocial moderation of polygenic risk for cannabis involvement: the role of trauma exposure and frequency of religious service attendance. Translational psychiatry, 9, 1-12. https://doi.org/10.1038/s41398-019-0598-z
  • Winiger, E.A., Ellingson, J.M., Morrison, C.L., Corley, R.P., Pasman, J.A., Wall, T.L., Hopfer, C.J., Hewitt, J.K. (2020). Sleep deficits and cannabis use behaviors: An analysis of shared genetics using linkage disequilibrium score regression and polygenic risk prediction, Sleep, zsaa188, https://doi.org/10.1093/sleep/zsaa188
  • Marees AT, Gamazon ER, Gerring Z, Vorspan F, Fingal J, van den Brink W, Smit DJA, Verweij KJH, Kranzler HR, Sherva R, Farrer L; International Cannabis Consortium, Gelernter J, Derks EM. Post-GWAS analysis of six substance use traits improves the identification and functional interpretation of genetic risk loci. Drug Alcohol Depend. 2020 Jan 1;206:107703. https://doi.org/10.1016/j.drugalcdep.2019.107703
  • Meyers JL, Salvatore JE, Aliev F, Johnson EC, McCutcheon VV, Su J, Kuo SI, Lai D, Wetherill L, Wang JC, Chan G, Hesselbrock V, Foroud T, Bucholz KK, Edenberg HJ, Dick DM, Porjesz B, Agrawal A. Psychosocial moderation of polygenic risk for cannabis involvement: the role of trauma exposure and frequency of religious service attendance. Transl Psychiatry. 2019 Oct 21;9(1):269. https://doi.org/10.1038/s41398-019-0598-z
  • Karlsson Linnér R, Biroli P, Kong E, Meddens SFW, Wedow R, Fontana MA, Lebreton M, Tino SP, Abdellaoui A, Hammerschlag AR, Nivard MG, Okbay A, Rietveld CA, Timshel PN, Trzaskowski M, Vlaming R, Zünd CL, Bao Y, Buzdugan L, Caplin AH, Chen CY, Eibich P, Fontanillas P, Gonzalez JR, Joshi PK, Karhunen V, Kleinman A, Levin RZ, Lill CM, Meddens GA, Muntané G, Sanchez-Roige S, Rooij FJV, Taskesen E, Wu Y, Zhang F; 23and Me Research Team; eQTLgen Consortium; International Cannabis Consortium; Social Science Genetic Association Consortium, Auton A, Boardman JD, Clark DW, Conlin A, Dolan CC, Fischbacher U, Groenen PJF, Harris KM, Hasler G, Hofman A, Ikram MA, Jain S, Karlsson R, Kessler RC, Kooyman M, MacKillop J, Männikkö M, Morcillo-Suarez C, McQueen MB, Schmidt KM, Smart MC, Sutter M, Thurik AR, Uitterlinden AG, White J, Wit H, Yang J, Bertram L, Boomsma DI, Esko T, Fehr E, Hinds DA, Johannesson M, Kumari M, Laibson D, Magnusson PKE, Meyer MN, Navarro A, Palmer AA, Pers TH, Posthuma D, Schunk D, Stein MB, Svento R, Tiemeier H, Timmers PRHJ, Turley P, Ursano RJ, Wagner GG, Wilson JF, Gratten J, Lee JJ, Cesarini D, Benjamin DJ, Koellinger PD, Beauchamp JP. Genome-wide association analyses of risk tolerance and risky behaviors in over 1 million individuals identify hundreds of loci and shared genetic influences. Nat Genet. 2019 Feb;51(2):245-257. https://doi.org/10.1038/s41588-018-0309-3
  • Soler Artigas M, Sánchez-Mora C, Rovira P, Richarte V, Garcia-Martínez I, Pagerols M, Demontis D, Stringer S; ADHD Group of the Psychiatric Genomics Consortium, International Cannabis Consortium, Vink JM, Børglum AD, Neale BM, Franke B, Faraone SV, Casas M, Ramos-Quiroga JA, Ribasés M. Attention-deficit/hyperactivity disorder and lifetime cannabis use: genetic overlap and causality. Mol Psychiatry. 2019 Jan 4. doi: 10.1038/s41380-018-0339-3. [Epub ahead of print]. https://www.nature.com/articles/s41380-018-0339-3
  • Allegrini AG, Verweij KJH, Abdellaoui A, Treur JL, Hottenga JJ, Willemsen G, Boomsma DI; International Cannabis Consortium, Vink JM. Genetic vulnerability for smoking and cannabis use: associations with e-cigarette and water pipe use. Nicotine Tob Res. 2018 Jul 19. doi: 10.1093/ntr/nty150. [Epub ahead of print]
  • Tielbeek JJ, Vink JM, Polderman TJC, Popma A, Posthuma D, Verweij KJH. Genetic correlation of antisocial behaviour with alcohol, nicotine, and cannabis use. Drug Alcohol Depend. 2018 Jun 1;187:296-299. doi: 10.1016/j.drugalcdep.2018.03.020.
  • Verweij KJ, Abdellaoui A, Nivard MG, Sainz Cort A, Ligthart L, Draisma HH, Minică CC; International Cannabis Consortium, Gillespie NA, Willemsen G, Hottenga JJ, Boomsma DI, Vink JM. Short communication: Genetic association between schizophrenia and cannabis use. Drug Alcohol Depend. 2017 Feb 1;171:117-121. doi: 10.1016/j.drugalcdep.2016.09.022. Erratum in: Drug Alcohol Depend. 2017 Apr 1;173:e1-e2.
  • Verweij KJH, Treur JL, Vink JM. Investigating causal associations between use of nicotine, alcohol, caffeine and cannabis: a two-sample bidirectional Mendelian randomization study. Addiction. 2018 Jul;113(7):1333-1338. doi: 10.1111/add.14154. Epub 2018 Feb 18.
  • Nivard MG, Verweij KJ, Minică CC, Treur JL; International Cannabis Consortium, Vink JM, Boomsma DI. Connecting the dots, genome-wide association studies in substance use. Mol Psychiatry. 2016 Jun;21(6):733-5. doi: 10.1038/mp.2016.14. Erratum in: Mol Psychiatry. 2016 Aug;21(8):1155-6.
  • Gage SH, Jones HJ, Burgess S, Bowden J, Davey Smith G, Zammit S and Munafò MR. Assessing causality in associations between cannabis use and schizophrenia risk: a two-sample Mendelian randomization study. Psychological Medicine. 2017, 47, 971-980.
Delen